| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/19/2004 | US20040034206 Administering therapeutically effective amount of ribavirin, (S)-N-3-(3-(3-methoxy-4-oxazol-5-yl-phenyl)ureido)benzylcarbam ic acid tetrahydrofuran-3-yl-ester, and pegylated interferon-alpha-2b |
| 02/19/2004 | US20040034202 Ketone spirocyclopropaneindene compounds; antineoplastic agents to inhibit tumor cell growth in vitro or in vivo; particularly effective against solid tumors and multi-drug resistant tumors |
| 02/19/2004 | US20040034107 Ubiquinone Qn for the treatment of pain |
| 02/19/2004 | US20040034106 Treatment of anxiety disorders |
| 02/19/2004 | US20040034105 Fewer side and/or analgesic effects |
| 02/19/2004 | US20040034103 Cdc25 photophatase inhibitors |
| 02/19/2004 | US20040034102 Oral pediatric trimethobenzamide formulations and methods |
| 02/19/2004 | US20040034101 Treatment and prevention of depression secondary to pain (DSP) |
| 02/19/2004 | US20040034100 Treating neuronal injury and for life-extension |
| 02/19/2004 | US20040034099 4-(bis(2-chloroethyl)amino)-L-phenylalanine derivatives and microcrystalline cellulose; antineoplastic agents |
| 02/19/2004 | US20040034098 Methods and compositions for preventing chronological aging in human skin |
| 02/19/2004 | US20040034096 3-Phenyl-propionamido, 3-phenyl-acrylamido and 3-phenyl-propynamido derivatives |
| 02/19/2004 | US20040034095 Low toxicity; side effect reduction |
| 02/19/2004 | US20040034094 Vitamin C stabilized topical formulation |
| 02/19/2004 | US20040034093 Methods for enhancing motor performance and/or endurance |
| 02/19/2004 | US20040034092 Such as 5,7,2-trihydroxy-6,8-dimethoxyflavone; plant extracts; side effect reduction; anxiolytic agents |
| 02/19/2004 | US20040034090 Such as (7-chloro-2-methyl-1-(3-(methylsulphanyl)propyl)-1H-indol-3-yl)(2,3-dichloro-phenyl)methanone; cannabinoid receptors (cb2); G proteins coupled receptors |
| 02/19/2004 | US20040034089 Such as (1-((2,3-dihydro-2-(4-propyl-1H-imidazol-2-yl)-1H-indol-1 -yl)carbonyl)propyl)-carbamate; for inactivation of cholecystokinins |
| 02/19/2004 | US20040034088 For treating microbial/fungal infections |
| 02/19/2004 | US20040034087 Comprises phosphodiesterase inhibitor and beta-2-adrenoceptor agonist; for treatment of respiratory tract disorders |
| 02/19/2004 | US20040034086 For treatment of diseases characterized by connective tissue breakdown, cartilage damage, and inflammation/pain such as arthritis, heart failure, multiple sclerosis, atherosclerosis, and osteoporosis |
| 02/19/2004 | US20040034084 Side effect reduction; for treatment of AIDS, cancer and arthritis |
| 02/19/2004 | US20040034083 Combination therapy for the treatment of Parkinson's disease with cyclooxygenase-2 (COX2) inhibitor(s) |
| 02/19/2004 | US20040034082 Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases |
| 02/19/2004 | US20040034081 Estrogen receptor modulators |
| 02/19/2004 | US20040034076 Such as methyl-3-azido-2-((4,6-dimethoxy-2-pyrimidinyl)oxy) 3,3-diphenylpropionate; for treatment of high blood pressure |
| 02/19/2004 | US20040034075 Sphingosine kinase inhibitors |
| 02/19/2004 | US20040034074 Comprises 3-(2-phenyl-2-oxoethyl)-4,5-dimethylthiazolium chloride; for inhibiting protein aging/non-enzymatic crosslinking; immunoassays; for treatment of cataracts |
| 02/19/2004 | US20040034073 Analgesic agents, modulating the activity of a cannabinoid receptor, treating hypertension, inflammation, pain, autoimmune diseases, allergic diseases, glaucoma, multiple sclerosis, Huntington's chorea, spinal chord injury |
| 02/19/2004 | US20040034072 Aza-amino acid derivatives (factor Xa inhibitors 15) |
| 02/19/2004 | US20040034070 Propanolaminotetralines, preparation thereof and compositions containing same |
| 02/19/2004 | US20040034069 Nitrogen-containing compounds and their use as glycine transport inhibitors |
| 02/19/2004 | US20040034068 New formulation and use thereof |
| 02/19/2004 | US20040034067 Administering pioglitazone or it's salt, a gamma-isoform of peroxisome proliferator activated receptor agonist, for treatment of a disease or condition associated with neutrophils |
| 02/19/2004 | US20040034066 Rosiglitazone hydrochloride is stable, water solubility, high melting point, bulk flow and good for bulk preparation and handling; salt formation |
| 02/19/2004 | US20040034065 A mixture of valsartan, an insulin secretion enhancer or a insulin sensitizer, for treating hypertension, congestive heart failure, diabetes, type 2 diabetes, renal failure, premenstrual syndrome, coronary heart disease |
| 02/19/2004 | US20040034064 2-(biarylalkyl)amino-3-(alkanoylamino)pyridine derivatives |
| 02/19/2004 | US20040034062 Novel aqueous anti-inflammatory pharmaceutical formulation |
| 02/19/2004 | US20040034061 An antagonist of corticotropin releasing factor receptor, treating depression, anxiety, Alzheimer's disease, Parkinson's disease, Huntington's chorea, eating disorder, hypertension, gastrointestinal disorders, drug dependence |
| 02/19/2004 | US20040034060 A cancer treatment using a 1-(3-chloro-phenyl)-pyrrolidine-2,5-dione derivatives, leucine zipper domains |
| 02/19/2004 | US20040034059 A dosage concentration about 0.4 to 75 mg/mL of fentanyl in water, for the pain treatment |
| 02/19/2004 | US20040034058 Inhalation asthma treatment with an aqueous solution of (2S)-3-(4-(((4-(aminocarbonyl)-1-piperidinyl)carbonyl)oxy) phenyl)-2-(((2S)-4-methyl-2-((2-(2-methylphenoxy)acetyl)amino) pentanoyl)amino) propanoic acid or a salt |
| 02/19/2004 | US20040034056 Method of preparation of (s)-n-tert-butyl-1,2,3,4-tetrahydroisoquinoline-3-carboxamide |
| 02/19/2004 | US20040034055 For treating central nervous system disorders, immunomodulatory disorders, antimalaria, viral disease of Borna virus, Hepatitis; a 6-azatricyclo(6.3.1.01,6)dodecane derivatives |
| 02/19/2004 | US20040034053 Veterinary treatment of ophthalmic disease in animals using toptical tacrolimus |
| 02/19/2004 | US20040034052 Antitumor agents |
| 02/19/2004 | US20040034049 A benzofuran derivatives for treating neurodegenerative disease, such as Alzheimer's disease, Parkinson's disease, amyotropic lateral sclerosis and Huntington's disease |
| 02/19/2004 | US20040034048 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 02/19/2004 | US20040034047 E.g. 5-(6,7-dimethoxy-2-(4-methoxybenzyl)benzofuran-4-yl-methyl-)pyrimidine-2,4 -diamine; bactericides for infections of grampositive and gramnegative pathogens; more potent than Trimethoprim, especially against respiratory tract pathogens |
| 02/19/2004 | US20040034046 Quinazoline derivatives |
| 02/19/2004 | US20040034045 Inhibitors of thrombin induced platelet aggregation |
| 02/19/2004 | US20040034042 Formulations containing a xanthine, e.g., caffeine, a buffer and a known preservative, e.g., sorbic acid, ethylenediamine-tetraacetic acid (EDTA) and salts; synergistic; storage stability; solutions and ointments of eyes; contact lenses |
| 02/19/2004 | US20040034041 Novel anti-infectives |
| 02/19/2004 | US20040034040 E.g., 5-(4-(3-chloro-4-methoxybenzylamino)-5,6,7,8-tetra-hydro-1-benzothieno(2,3 -d) pyrimidin-2-yl)valeric acid to treat high pullmonary pressure; hypotensive agents; liver, cardiovascular, kidney and sexual disorders; antiallergens |
| 02/19/2004 | US20040034039 An oval tablet comprising a drug, e.g., an antigonadotrophin, a slightly water-soluble, water-repellant, cellulose-type disintegrant, a binder and a stearate lubricant; improved granulability; storage stability; drug delivery; oval tablets |
| 02/19/2004 | US20040034037 Heteroaryl compounds useful as inhibitors of GSK-3 |
| 02/19/2004 | US20040034036 A serotonin 6 (5-HT6) receptor antagonist useful in the treatment of CNS disorders; oral bioavailability; Alzheimers disease; cognitive activators; attention deficit disorder; antidepressants; anxiolytic agents; headaches; hyperactivity |
| 02/19/2004 | US20040034035 Calcium channel inhibitors comprising benzhydril spaced from piperazine |
| 02/19/2004 | US20040034034 Novel piperazine derivatives |
| 02/19/2004 | US20040034032 Quinoline and quinazoline compounds useful in therapy |
| 02/19/2004 | US20040034031 3,4-Disubstituted, 3,5-disubstituted and 3,4,5-substituted piperidines |
| 02/19/2004 | US20040034030 A unit dosage form as adjuvant to biguanide (metformin) or sulfonylurea (glyburide) therapy for supporting mitochondrial metabolism containing carnitine, ascorbic acid, choline, taurine, foic acid and magnesium; side-effect reduction |
| 02/19/2004 | US20040034029 Composition and method for altering levels of or sensitivity to adenosine with a dehydroepiandrosterone |
| 02/19/2004 | US20040034028 4-(biphenylcarbonylamino)piperidine derivatives as mtp inhibitors |
| 02/19/2004 | US20040034027 E.g.N-(carbamimidoylphenyl)-N'-((1-(4-nitrophenyl)ethyl-2-phenyl -malonamide formate; reversible enzyme inhibitors of blood factor VIIa; a strong antithrombotic to treat thrombo-embolic diseases and restenoses; cardiovascular disorders |
| 02/19/2004 | US20040034026 The use of a vasculostatic compound and a second active ingredient which decreases the activity of the epidermal growth factor (EGF); synergistic, angiogenesis inhibitors; antiproliferative agents; tyrosine kinase enzyme inhibitors |
| 02/19/2004 | US20040034025 Having a high residual activity, greater activity at lower application rates, curative activity, and a broader spectrum of efficacy; heterocyclic aromatic amides having a hydroxy group adjacent to the amide functionality |
| 02/19/2004 | US20040034024 E.g., N-Formyl-N-hydroxy-2-(m-biphenoxy)ethylamine; treating a bacterial infection (including respiratory tract infection and/or grampositive bacteria infections (staphylococci, strepococci, and enterococci); antibiotics |
| 02/19/2004 | US20040034023 Dibenzophenanthrolines useful for treating cancer |
| 02/19/2004 | US20040034022 Polymorphic forms/hydrates of n-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride |
| 02/19/2004 | US20040034021 Intravenous rifalazil formulation and methods of use thereof |
| 02/19/2004 | US20040034020 A purine deriveative, useful for treatment of inflammatory conditions, immune disorders, tissue injury, infections, and cancer |
| 02/19/2004 | US20040034019 Piperazine and piperidine derivatives |
| 02/19/2004 | US20040034018 2-amino-trihydroindole or tetrahydronapthalene-2-yl derivatives, useful for disease state associated with smooth muscle disorders, such as gastrointestinal and urogenital disorders |
| 02/19/2004 | US20040034017 4-fluoroalkyl-2h-benzopyrans anti-estogenic activity |
| 02/19/2004 | US20040034016 Diuretic or sulphonylurea for use in antiviral treatment |
| 02/19/2004 | US20040034015 Administering to a human patient suffering from addictive behavior associated with 5HT2C receptor modulation, a fused tetra or pentaheterocyclic compound containing nitrogen in the rings |
| 02/19/2004 | US20040034014 3,7-dihydro-purine-2,6-dione derivatives useful for treating obesity and type II diabetes |
| 02/19/2004 | US20040034013 Methods of treatment |
| 02/19/2004 | US20040034010 Administering an effective amount of quetiapine or a salt to a patient having attention deficit hyperactivity disorder or conduct disorder |
| 02/19/2004 | US20040034008 N-alkylpiperdino-4-yl-urea-pyrazole derivative for treating obesity, metabolic disorders, eating disorders and diabetes |
| 02/19/2004 | US20040034005 Administering to a patient suffering from psychological disoders a (1,4)diazocino(7,7,1-hi)inodle derivative as 5HT2c agonist or partial agonist |
| 02/19/2004 | US20040034004 Bicyclic heterocycles for the treatment of diabetes and other diseases |
| 02/19/2004 | US20040034003 7-Hydroxy-16alpha-fluoro-5-androsten-17-ones and 7-hydroxy-16alpha-fluoro-5-androstan-17-ones and derivatives thereof |
| 02/19/2004 | US20040034002 3Alpha-hydroxy-3beta-methoxymethyl-substituted steroids and the use thereof |
| 02/19/2004 | US20040034001 Administering to the female patient undergoing hormone replacement therapy, an effective amounts of drospirenone (DRSP) and at least one estrogen to reduce the blood pressure |
| 02/19/2004 | US20040034000 Methods of treating and/or suppressing insulin resistance |
| 02/19/2004 | US20040033999 Testosterone derivative |
| 02/19/2004 | US20040033998 (20S)-1alpha-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses |
| 02/19/2004 | US20040033997 Compositions and methods for preventing sporadic neoplasia in colon |
| 02/19/2004 | US20040033996 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 02/19/2004 | US20040033995 Nitrogen compounds, stereoisomers and/or racemic mixtures used as enzyme inhibitors for prophylaxis of inflammatory diseases |
| 02/19/2004 | US20040033994 Use of compounds comprising a nitrogen-oxygen heterocycle |
| 02/19/2004 | US20040033993 Treatment of cardiovascular and related pathologies |
| 02/19/2004 | US20040033992 Treatment of cardiovascular and related pathologies |
| 02/19/2004 | US20040033991 Treating of cardiovascular and related pathologies |
| 02/19/2004 | US20040033990 Administering mixtures of heterocyclic imines, calcium channel blockers, adrenergic blocking agents, anticoagulants, diuretics and angiotensin converting enzyme inhibitors, for prophylaxis of heart diseases such as arrhythmias or necrosis |
| 02/19/2004 | US20040033989 Treatment of cardiovascular and related pathologies |
| 02/19/2004 | US20040033988 Sulfur compounds such as 2-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-N-hydroxy-3-methyl -butyramide, used as tumor necrosis factor-alpha converting enzyme (TACE) inhibitors, for prophylaxis of rheumatic diseases, sepsis or inflammation |
| 02/19/2004 | US20040033987 Phosphorus compounds such as 1-palmitoyl-2-valproyl-glycero-3-phosphatidylcholine, used for prohylaxis of nervous system disorders such as epilepsy, migraine, bipolar disorders and pain |